In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phthalate Cosmetics Survey Placed On CFSAN Priority List

This article was originally published in The Rose Sheet

Executive Summary

Amid growing controversy over the use of phthalates in cosmetics, FDA's Center for Food Safety & Applied Nutrition announced that a review of the chemicals is one of the Office of Cosmetics & Colors "A" list priorities for fiscal 2004 (ending Sept. 30)
Advertisement

Related Content

FDA Phthalate Study Finds Highest Levels Of Substance In Nail Polish
FDA Phthalate Study Finds Highest Levels Of Substance In Nail Polish
Cosmetic Claim Review Should Not Make CFSAN Priority Cut – CTFA
Proposed Calif. Phthalates Ban Revived; Headed To Senate Floor
CFSAN program priorities
Carcinogens In Cosmetics Need Oversight, Environmental Group Claims
California Health Groups To Sustain Push For Phthalates Ban In Cosmetics
California Health Groups To Sustain Push For Phthalates Ban In Cosmetics
Phthalate Exposure Levels Stratified By Age, Gender In CDC Report
Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results
Advertisement
UsernamePublicRestriction

Register

RS012118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel